BETHEL, Conn., June 25, 2007 (PRIME NEWSWIRE) -- Aduromed Industries Inc. (OTCBB:ADRM) today announced the second installation this quarter of an Aduromed MedClean(tm) MC4 Series medical waste treatment and processing system. The system has been installed at the Medical Center of the Rockies in Loveland, CO.
"We have made tremendous strides in strengthening our design, pre-installation planning and project management infrastructure which has enabled us to complete one of our smoothest installations to date with all aspects of this project being performed ahead of schedule and on budget," stated Damien R. Tanaka, Aduromed Industries President and CEO.
As with other MedClean Systems operating in major hospitals and medical centers throughout the country, the installation at the Medical Center of the Rockies is a fully integrated system that includes medical waste collection, transportation, sterilization, material destruction and final disposal as non-hazardous municipal waste. This technology efficiently addresses the issues of most concern to healthcare professionals -- safety, regulatory compliance and significant cost savings. The system also enables any institution to destroy all of its HIPAA documents in a regulatory compliant manner, thereby avoiding costly outsourcing and further enhancing the return on investment.
The installation at the Medical Center of the Rockies follows closely behind the recently completed installation at Provena St. Joseph's Medical Center in Joliet, Illinois. In the last 12 months Aduromed has installed 11 systems, including these two recent additions.
Currently operating MedClean Systems annually sterilize and shred in excess of 17 million pounds of medical waste at healthcare customer facilities around the United States, thereby avoiding the transportation of bio-hazardous materials on public highways and reducing waste volume.
About Aduromed Corporation:
Aduromed is one of the largest modern day providers of systems for the onsite disposal of medical waste that incorporate the design, installation and servicing of turnkey systems to treat infectious regulated medical waste (RMW). It provides proprietary equipment and systems for efficient, safe, cost effective and legally compliant alternative solutions to incineration or off-site hauling of untreated waste, and to other treatment technologies and methodologies. With a strong base of suppliers and clients it is positioned for significant growth within the medical waste industry.
Aduromed's MedClean(tm) Series System treats and processes all forms of regulated medical waste, sterilizing the waste prior to rendering the sterilized waste unrecognizable and through use of a unique and proprietary dual-stage shredding machine, converts such waste into safe solid waste (SSW) for disposal into a normal landfill. The System is part of Aduromed's MedClean Program, which incorporates collection, transportation and processing of medical waste on site, and eliminates any manual handling or transfer of the medical waste until its conversion into SSW, thereby protecting the operator and limiting liability for the institutions using the Program. The unique design and arrangement of the System's components make it the smallest footprint within an industry where real estate is at a premium. Each MedClean Series System installation is sized appropriately to ensure ample capacity to treat and process medical waste efficiently and effectively.
The current U.S. medical waste market is estimated to be $3 billion. Further Information on Aduromed can be found at www.aduromed.com, and in filings with the Securities and Exchange Commission found at www.sec.gov.
This press release and the information incorporated by reference may include "forward looking statements": within the meaning of applicable Federal Securities Laws. The Company intends the forward looking statements to be covered by the safe harbor provisions for forward looking statements. All statements regarding the Company's expected financial position and operating results, its business strategy, its financing plans and the outcome of any contingencies are forward looking statements. The forward looking statements are based on current estimates and projections about our industry and our business. Words such as "anticipates," "expects," intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward looking statements. The forward looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward looking statements, including those set forth in our most recent Annual Report on Form 10-KSB for the year ended December 31, 2006, filed with the SEC on March 30, 2007,and other filings with the SEC, and are subject to change at any time. The Company assumes no obligation to update publicly the forward looking statements contained herein, whether as a result of new information, future events or otherwise, except as may be required by law.